Certifications 2

MSDS-No.: 232327
V005.0
Loctite 7061 400ml, ML
Page 11 of 16
Germ cell mutagenicity:
Hazardous components
CAS-No.
Result
Type of study /
Route of
administration
Metabolic
activation /
Exposure time
Species
Method
Acetone
67-64-1
negative
bacterial reverse
mutation assay (e.g
Ames test)
with and without
OECD Guideline 471
(Bacterial Reverse Mutation
Assay)
negative
in vitro mammalian
chromosome
aberration test
with and without
OECD Guideline 473 (In vitro
Mammalian Chromosome
Aberration Test)
negative
mammalian cell
gene mutation assay
without
OECD Guideline 476 (In vitro
Mammalian Cell Gene
Mutation Test)
Acetone
67-64-1
negative
oral: drinking water
mouse
not specified
Ethanol
64-17-5
negative
bacterial reverse
mutation assay (e.g
Ames test)
OECD Guideline 471
(Bacterial Reverse Mutation
Assay)
negative
in vitro mammalian
chromosome
aberration test
without
OECD Guideline 473 (In vitro
Mammalian Chromosome
Aberration Test)
negative
mammalian cell
gene mutation assay
with and without
OECD Guideline 476 (In vitro
Mammalian Cell Gene
Mutation Test)
Ethanol
64-17-5
negative
OECD Guideline 475
(Mammalian Bone Marrow
Chromosome Aberration Test)
Propan-2-ol
67-63-0
negative with
metabolic
activation
mammalian cell
gene mutation assay
with and without
OECD Guideline 476 (In vitro
Mammalian Cell Gene
Mutation Test)
Propan-2-ol
67-63-0
negative
intraperitoneal
mouse
OECD Guideline 474
(Mammalian Erythrocyte
Micronucleus Test)
Carcinogenicity:
Hazardous components
CAS-No.
Result
Species
Sex
Exposure
timeFrequenc
y of treatment
Route of
application
Method
Acetone
67-64-1
not carcinogenic
mouse
female
424 d
3 times per
week
dermal
not specified
Ethanol
64-17-5
rat
oral:
unspecified
not specified
Ethanol
64-17-5
mouse
female
dermal
not specified
Ethanol
64-17-5
mouse
male
inhalation
not specified
Propan-2-ol
67-63-0
rat
male/female
104 w
6 h/d, 5 d/w
inhalation:
vapour
OECD Guideline 451
(Carcinogenicity Studies)